HHRI News & Press Releases
Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read MoreAbout Hennepin Healthcare Research Institute
Our Research Home » About Hennepin Healthcare Research Institute At the Hennepin Healthcare Research Institute (HHRI), we have been actively investigating the causes of and potential treatments for diseases since 1952. We support and oversee the medical research conducted at HCMC, the flagship acute care and teaching hospital of the…
Read More